Analysis system

By introducing multiple measurement modes and automatic mode selection functions of the management department in the analysis system, the problem of operator burden caused by the diversity of the examination content is solved, and the rapid and accurate examination analysis is achieved.

CN119000906APending Publication Date: 2024-11-22ARKRAY INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410600573.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2023-05-18
Filing Date
2024-05-15
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

In the case of a mixture of multiple examination contents, the inspection operator needs to frequently set and switch the measurement mode of the analysis device, resulting in an increase in burden.

Method used

Design an analysis system, including an analysis unit and a management unit with multiple measurement modes. The management unit automatically selects an appropriate measurement mode based on the diagnosis and treatment department information of the sample to ensure that the analysis unit can switch and execute the first measurement mode and the second measurement. model.

Benefits of technology

It effectively reduces the burden on inspection workers, ensuring that even if the examination content is different, analysis can be carried out quickly and accurately to avoid setting errors.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119000906A_ABST
    Figure CN119000906A_ABST
Patent Text Reader

Abstract

This analysis system is provided with: an analysis unit that analyzes a specimen and is capable of switching between a first measurement mode and a second measurement mode that includes a measurement item different from the first measurement mode; and a management unit that selects a measurement mode from the first measurement mode and the second measurement mode of the analysis unit on the basis of information of a medical department for which an examination set for the specimen has been requested.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present disclosure relates to analytical systems. Background Art

[0002] As an apparatus for analyzing hemoglobin in blood, an analysis apparatus using liquid chromatography is known (see Japanese Patent Application Laid-Open Nos. 2017-198666 and 2019-60655). Summary of the invention

[0003] Problems to be solved by the invention

[0004] The contents of examination of specimens including blood are often different depending on the department of medical treatment that requests the examination. In addition, specimens with different examination contents are mixed together when they arrive at the examination room where the specimens are examined. The operator in the examination room sets the measurement mode of the analyzer according to the examination contents of the specimens. When setting the measurement mode according to the examination contents of the specimens, it is necessary to be careful not to make setting errors, which tends to increase the burden on the operator.

[0005] An object of the present disclosure is to provide an analysis system that can suppress an increase in the burden on an inspection operator even when specimens with different inspection contents are mixed in a configuration in which a specimen is analyzed using an analysis unit having a plurality of measurement modes.

[0006] Technical solutions to solve problems

[0007] An analysis system according to one embodiment of the present disclosure includes:

[0008] an analyzing unit that analyzes the sample and is capable of switching between a first measurement mode and a second measurement mode including measurement items different from those in the first measurement mode; and

[0009] The management unit selects a measurement mode from among the first measurement mode and the second measurement mode of the analysis unit based on information of the medical department that has requested the examination set for the sample.

[0010] Effects of the Invention

[0011] According to the analysis system of the present disclosure, in a configuration in which a sample is analyzed using an analysis unit having a plurality of measurement modes, even if samples having different test contents are mixed, an increase in the burden on test workers can be suppressed. BRIEF DESCRIPTION OF THE DRAWINGS

[0012] Figure 1 It is a schematic structural diagram of an analysis device according to an embodiment.

[0013] Figure 2 It is a block diagram of a control system of the analysis system according to the embodiment.

[0014] Figure 3 It is a flow chart of the liquid chromatography determination procedure.

[0015] Figure 4 This is a flowchart of the sample measurement mode selection procedure.

[0016] Figure 5 It is a block diagram of a control system of an analysis system according to a modified example. DETAILED DESCRIPTION

[0017] Hereinafter, an analysis system according to one embodiment of the present disclosure will be described. In addition, the dimensions, materials, shapes, relative arrangements, etc. of the components described in the embodiments do not limit the technical scope of the invention to these only unless otherwise specified.

[0018] like Figure 2 As shown, the analysis system 20 of the present embodiment includes an analysis device 30 and a management device 80 .

[0019] (Analysis device 30)

[0020] Figure 1 The schematic structure of the analysis device 30 is shown.

[0021] The analysis device 30 is a device for analyzing the components of the specimen. Specifically, the analysis device 30 is a device for measuring the concentration of HbA1c in the blood using high performance liquid chromatography (HPLC). In addition, the analysis device 30 is an example of the analysis unit disclosed in the present invention. In addition, the analysis unit disclosed in the present invention may also be an analysis device for analyzing other components of the specimen (biological sample).

[0022] like Figure 1 As shown, as an example, the analysis device 30 includes a plurality of eluent bottles 32A, 32B, 32C, 32D, and 32E (in Figure 1 five in the middle).

[0023] The eluent bottles 32A, 32B, 32C, 32D, and 32E respectively hold eluents A, B, C, D, and E to be supplied to an analytical column 44 described later. The eluents differ in composition, component ratio, pH, osmotic pressure, etc., depending on the application.

[0024] In addition, as an example, the analysis device 30 includes a sample preparation unit 34 , an analysis unit 36 ​​, and a photometry unit 38 .

[0025] The sample preparation unit 34 is a unit having a function of preparing a sample to be introduced into the analysis column 44 from the blood sample 102 collected in the blood collection tube 100. The sample preparation unit 34 includes, for example, a nozzle 40 and a dilution tank 42. The nozzle 40 is used to collect various liquids including the blood sample 102 from the blood collection tube 100. The dilution tank 42 is a tank for diluting the blood sample 102, and the blood sample 102 collected by the nozzle 40 is supplied.

[0026] The analysis unit 36 ​​is a unit having a function of controlling the adsorption and desorption of biological components to the filler of the analysis column 44 and supplying various biological components to the photometric unit 38. The analysis unit 36 ​​includes the analysis column 44, a manifold 46, a liquid delivery pump 48, and an injection valve 50.

[0027] The analytical column 44 is a device that holds a filler for selectively adsorbing hemoglobin in the blood sample 102 .

[0028] Manifold 46 is the part that selectively supplies eluent to analytical column 44 from the specific eluent bottle in a plurality of eluent bottles 32A, 32B, 32C, 32D, 32E.This manifold 46 is connected with eluent bottle 32A, 32B, 32C, 32D, 32E respectively via pipe arrangement 52A, 52B, 52C, 52E, and is connected with injection valve 50 via pipe arrangement 54.

[0029] The liquid delivery pump 48 is a pump for providing power to move the eluent toward the injection valve 50 . The liquid delivery pump 48 is provided in the middle of the pipe 54 .

[0030] The injection valve 50 is a valve capable of collecting a certain amount of an introduction sample and introducing the introduction sample into the analytical column 44. The injection valve 50 has a plurality of introduction ports and discharge ports (not shown). In addition, an injection ring 56 is connected to the injection valve 50. The injection ring 56 can hold a certain amount of liquid. By appropriately switching the injection valve 50, it is possible to select a state in which the injection ring 56 is connected to the dilution tank 42 and the introduction sample is supplied from the dilution tank 42 to the injection ring 56, and a state in which the injection ring 56 is connected to the analytical column 44 via the pre-filter PF and the piping 58 and the introduction sample is introduced from the injection ring 56 to the analytical column 44.

[0031] The photometric unit 38 is a device for optically detecting hemoglobin contained in the desorbed liquid from the analytical column 44. The photometric unit 38 is connected to a waste liquid tank 60 for discharging the desorbed liquid from the analytical column 44 via a pipe 58.

[0032] Figure 2 1 shows a block diagram of the control system of the analysis device 30. Figure 2As shown, the analysis device 30 includes a control unit 70. The control unit 70 includes a CPU (Central Processing Unit) 70A, a ROM (Read Only Memory) 70B, a RAM (Random Access Memory) 70C, a non-volatile memory 70D, an input / output interface (I / O) 70E, and a bus 70F. The CPU 70A, the ROM 70B, the RAM 70C, the non-volatile memory 70D, and the input / output interface 70E are connected to each other via the bus 70F.

[0033] The sample preparation unit 34 , the analysis unit 36 ​​, and the photometry unit 38 are connected to the input / output interface 70E, respectively.

[0034] In addition, the liquid chromatography measurement program described later is pre-stored in the non-volatile memory 70D as an example in this embodiment. The CPU 70A reads and executes the liquid chromatography measurement program stored in the non-volatile memory 70D. In addition, for example, the liquid chromatography measurement program can also be recorded on a recording medium such as a CD-ROM, and the program can be read and executed by using a CD-ROM drive or the like.

[0035] Furthermore, the control unit 70 is connected to an external communication unit 72 , a barcode reader 74 , an operation unit 76 , and a display unit 78 .

[0036] The external communication unit 72 is a device for communicating with the outside via a network line.

[0037] The barcode reader 74 reads the barcode attached to the blood sampling tube 100 containing the blood sample 102 as a specimen. The barcode information read by the barcode reader 74 is transmitted to the management device 80 described later via the external communication unit 72. In the management device 80, a measurement mode for the blood sample 102 is selected based on the barcode information of the blood sampling tube 100, and the measurement mode is transmitted to the control unit 70 (CPU 70A) via the external communication unit 72. The so-called barcode information is information inherent to the specimen, such as the specimen ID.

[0038] The operation unit 76 is a portion that receives input from an inspection operator.

[0039] The display unit 78 displays the operation contents of the operation unit 76, a measurement mode described later, etc. In addition, a chromatogram drawn based on the detection result of the photometric unit 38 may be displayed.

[0040] The analyzer 30 has at least two measurement modes. Specifically, the analyzer 30 has a first measurement mode and a second measurement mode, and is configured to be switchable between the first measurement mode and the second measurement mode.

[0041] The first measurement mode is a mode for measuring the specimen more quickly than the second measurement mode. Here, the so-called more quickly measurement means, for example, that the time until the measurement result is obtained (measurement time) is shorter than that in the second measurement mode. The main reason for the shortening of the measurement time of the specimen is that the measurement result is obtained as simple information (when the measurement result is numerical data, the number of digits after the decimal point of the numerical data is small, etc.), or the number of measurement items is small.

[0042] The second measurement mode is a mode for measuring the specimen in more detail than the first measurement mode. Here, the so-called more detailed measurement includes, for example, measurement items different from those in the first measurement mode, or the measurement time of the specimen is longer than that in the first measurement mode. The main reason for the increase in time until the measurement result is obtained is that the measurement result is obtained as detailed information (when the measurement result is numerical data, the number of digits below the decimal point of the numerical data is large, etc.).

[0043] In the analyzing device 30 of the present embodiment, the rapid mode is set as an example of the first measurement mode, and the variant mode is set as an example of the second measurement mode.

[0044] Here, the so-called variant mode is a mode for measuring HbA1c and variant hemoglobin in the blood sample 102 as measurement items by sequentially sending a plurality of eluents described later to the analytical column 44 in a predetermined order using liquid chromatography. In the variant mode of the present embodiment, for example, HbA1c, HbA0, HbF, HbS, and HbC can be measured.

[0045] The rapid mode is a mode for measuring HbA1c by sequentially conveying a plurality of common eluents common to the eluent used in the variant mode to the analytical column 44 in a predetermined order, and is a mode for rapid measurement that is dedicated to measuring HbA1c as a measurement item. In the rapid mode of the present embodiment, for example, HbA1c, HbA0, and HbF can be measured.

[0046] That is, the variant mode is a mode that includes detailed measurements of measurement items different from the rapid mode. Specifically, the variant mode has more measurement items than the rapid mode, so the measurement time is longer.

[0047] (Management device 80)

[0048] Figure 2 The schematic structure of the management device 80 is shown.

[0049] The management device 80 is a device capable of managing at least one analysis device 30. In addition, the management device 80 is an example of a management unit in the present disclosure.

[0050] Figure 2 FIG. 8 is a block diagram of a control system of the management device 80. Figure 2 As shown, the management device 80 includes a CPU (Central Processing Unit) 80A, a ROM (Read Only Memory) 80B, a RAM (Random Access Memory) 80C, a nonvolatile memory 80D, and a bus 80E. The CPU 80A, the ROM 80B, the RAM 80C, and the nonvolatile memory 80D are connected to each other via the bus 80E.

[0051] In addition, the sample measurement mode selection program described later is pre-stored in the non-volatile memory 80D as an example in this embodiment. The CPU 80A reads and executes the sample measurement mode selection program stored in the non-volatile memory 80D. In addition, for example, the sample measurement mode selection program can also be recorded on a recording medium such as a CD-ROM, and the program can be read and executed by using a CD-ROM drive or the like.

[0052] Furthermore, the management device 80 is connected to an external communication unit 82 , an operation unit 84 , a display unit 86 , and a database 88 .

[0053] The external communication unit 82 is a device for communicating with the outside via a network line. Through the external communication unit 82, the management device 80 can communicate with the analysis device 30. In addition, the network line mentioned here can be a local information communication network (LAN) constructed in the medical institution where the analysis device 30 and the management device 80 are installed, or it can be a communication line such as the Internet.

[0054] The operation unit 84 is a portion that receives input from an operator.

[0055] The display unit 86 displays the operation contents of the operation unit 84 , a measurement mode described later, and the like.

[0056] The database 88 stores information related to the inspection contents of the blood sample 102 (hereinafter referred to as "inspection information" as appropriate). The inspection contents of the blood sample 102 referred to here refer to the components (referred to as "measurement items") contained in the blood sample 102 as the measurement object. The inspection information of the blood sample 102 is stored in association with the barcode information corresponding to the blood sample 102 (the information of the barcode attached to the blood collection tube 100).

[0057] The examination information of the blood sample 102 includes information of the medical department that has requested the blood sampling room in the hospital for the patient's blood sampling examination (hereinafter referred to as "medical department information" as appropriate). In addition, the medical department information includes not only medical departments in the same hospital, but also medical departments in different hospitals such as branch hospitals.

[0058] Furthermore, the test information of the blood sample 102 is input by a person belonging to the medical department who has requested the blood sampling test, and is sent to the management device 80 via a support system such as a laboratory information management system provided by the external device 190 , and is thereby stored in the database 88 .

[0059] In addition, information associating the medical department information with the measurement mode is stored in the database 88. For example, when the medical department information is diabetes internal medicine, the measurement is performed in the variant mode, and when the medical department information is health examination department, the measurement is performed in the rapid mode. The information associating the medical department information with the measurement mode can also be arbitrarily input by the user from the operation unit 84.

[0060] After receiving the inquiry about the measurement mode of the blood sample 102 from the analyzer 30 (in other words, receiving the barcode information of the blood sample 102), the CPU 80A selects the measurement mode of the blood sample 102 from the rapid mode and the variant mode based on the information associating the diagnosis and treatment department information with the measurement mode stored in the database 88. Then, the selected measurement mode is transmitted to the analyzer 30.

[0061] Next, the analysis operation of the blood sample 102 by the analysis device 30 will be described.

[0062] Figure 3 An example of a flowchart of a liquid chromatography measurement process executed by the CPU 70A of the control unit 70 is shown.

[0063] First, the inspection operator sets the blood collection tube 100 containing the blood sample 102 in the analysis device 30. Specifically, the analysis device 30 is provided with a rack 104 that accommodates a plurality of (e.g., 10) blood collection tubes 100. The set rack 104 is transported by a transport device (not shown) provided in the analysis device 30 to a collection position where the blood sample 102 is collected from the blood collection tube 100.

[0064] When the inspection operator instructs the analyzer 30 to start measurement, the CPU 70A reads and executes the liquid chromatography measurement program stored in the nonvolatile memory 70D.

[0065] In step S200, the barcode information read from the barcode of the blood collection tube 100 by the barcode reader 74 is transmitted to the management device 80. In the present embodiment, the barcodes of all the blood collection tubes 100 are continuously read by the barcode reader 74, and each read information is transmitted to the management device 80. However, the barcode of the blood collection tube 100 may be read by the barcode reader 74 each time the blood sample 102 is analyzed.

[0066] In step S202, the measurement mode of the blood sample 102 is acquired from the management device 80. In the present embodiment, the measurement mode of all the blood samples 102 is acquired from the management device 80, but the measurement mode may be acquired from the management device 80 each time the blood sample 102 is analyzed.

[0067] In step S204, it is determined whether the measurement mode obtained from the management device 80 is the quick mode. If it is the quick mode, the process proceeds to step S206. On the other hand, if the measurement mode obtained from the management device 80 is not the quick mode, the process proceeds to step S220.

[0068] The multiple eluents used in this embodiment are liquid A, liquid B, and liquid C. Liquid A is, for example, an eluent for eluting HbA1c and for equilibrating the analytical column 44. Liquid B is, for example, an eluent for eluting all hemoglobin remaining in the analytical column 44, that is, an eluent for washing the analytical column 44. Liquid C is, for example, an eluent for eluting hemoglobin other than HbA1c after HbA1c is eluted. In addition, the order of hemoglobin elution ability from high to low is liquid B, liquid C, and liquid A.

[0069] In the variant mode, liquid A, liquid B, and liquid C are delivered to the analytical column 44 in a predetermined order for measurement. In the rapid mode, liquid A and liquid B are delivered to the analytical column 44 in a predetermined order for measurement. That is, liquid A and liquid B are common eluents used in both the variant mode and the rapid mode, and liquid C is a non-common eluent used only in the variant mode.

[0070] In step S206, the blood sample 102 is introduced. Specifically, the blood sample 102 is collected from the blood collection tube 100 by operating the nozzle 40. The blood sample 102 collected by the nozzle 40 is supplied to the dilution tank 42 by operating the nozzle 40.

[0071] Then, by switching the injection valve 50, the sample held in the injection loop 56 is filtered by the prefilter PF and introduced into the analytical column 44. When the sample is introduced into the analytical column 44, HbA1c, variant Hb, and the like are adsorbed on the filler.

[0072] In step S208 , liquid A is supplied to the analytical column 44 for a predetermined time period. Thus, HbA1c is eluted from the analytical column 44 .

[0073] In step S210, solution B is supplied to the analytical column 44 for a predetermined time period. As a result, all the hemoglobin remaining in the analytical column 44 is eluted, and the analytical column 44 is cleaned.

[0074] In step S212, liquid A is supplied to the analytical column 44 for a predetermined time period, thereby equilibrating the analytical column 44.

[0075] Thus, in the rapid mode, the liquids are fed to the analytical column 44 in the order of liquid A→liquid B→liquid A.

[0076] The desorbed liquid containing various hemoglobins discharged from the analytical column 44 is supplied to the photometric unit 38 via the pipe 58. The desorbed liquid is introduced into the waste liquid tank 60 via the pipe 58.

[0077] In the photometric unit 38, the desorbed liquid is continuously irradiated with light, and the light reception result (absorbance) is output to the control unit 70. Then, the control unit 70 calculates the chromatogram.

[0078] A chromatogram is a graph showing the relationship between the time elapsed from the start of measurement and the absorbance as a result of receiving light. From where the peak of the chromatogram appears, it is possible to know which hemoglobin is detected, and from the cumulative value of the absorbance at the peak part (mountain part), that is, the size of the area of ​​the peak part, it is possible to know the concentration of hemoglobin.

[0079] In step S214, HbA1c is measured based on the calculated chromatogram.

[0080] In step S216, the measurement result is stored in the nonvolatile memory 70D. That is, the HbA1c concentration and the presence or absence of detected mutant hemoglobin are stored in the nonvolatile memory 70D.

[0081] In step S218, it is determined whether the above-mentioned measurement has been completed for all blood sampling tubes 100. If the measurement has been completed for all blood sampling tubes 100, this routine is terminated. If there are blood sampling tubes 100 for which the measurement has not been completed, the routine returns to step S204 to determine whether the measurement mode for the blood sample 102 as the measurement object obtained from the management device 80 is the rapid mode.

[0082] In step S204 , when it is determined that the measurement is not in the rapid mode, that is, in the variant mode, the process proceeds to step S220 .

[0083] In step S220, the blood sample 102 is introduced in the same manner as in step S206.

[0084] In step S222 , liquid A is supplied to the analytical column 44 for a predetermined time period. Thus, HbA1c is eluted from the analytical column 44 .

[0085] In step S224, the C solution is supplied to the analytical column 44 for a predetermined time. Thus, after HbA1c is eluted from the analytical column 44, hemoglobin other than HbA1c is eluted.

[0086] In step S226, liquid A is supplied to the analytical column 44 for a predetermined time period, thereby equilibrating the analytical column 44.

[0087] In step S228, solution B is supplied to the analytical column 44 for a predetermined time. Thus, all the hemoglobin remaining in the analytical column 44 is eluted, and the analytical column 44 is cleaned.

[0088] In step S230, liquid A is supplied to the analytical column 44 for a predetermined time period, thereby equilibrating the analytical column 44.

[0089] Thus, in the variation mode, the liquids are fed to the analytical column 44 in the order of liquid A→liquid C→liquid A→liquid B→liquid A.

[0090] In step S232, HbA1c is measured in the same manner as in step S214.

[0091] In step S234, variant hemoglobin is measured based on the calculated chromatogram.

[0092] In step S236, the measurement results are stored in the nonvolatile memory 70D. That is, the concentration of HbA1c and the concentration of variant hemoglobin are stored in the nonvolatile memory 70D.

[0093] As described above, in the present embodiment, based on the instruction of the management device 80 , it is possible to switch between the quick mode and the variant mode in one device and perform measurement.

[0094] Next, the flow of selecting the measurement mode of the blood sample 102 by the management device 80 will be described.

[0095] Figure 4 An example of a flowchart of the sample measurement mode selection process executed by the CPU 80A of the management device 80 is shown.

[0096] When receiving the information (barcode information) related to the blood sample 102 from the analyzer 30 , the CPU 80A reads and executes the sample measurement mode selection program stored in the nonvolatile memory 80D.

[0097] In step S300, the CPU 80A accesses the database 88 based on the barcode information of the blood sample 102, and specifies the information of the medical department (medical department information) that has requested the blood sampling test corresponding to the barcode information.

[0098] In step S302, the CPU 80A determines whether the measurement mode of the blood sample 102 is the rapid mode or the variant mode based on the information that associates the medical department information with the measurement mode stored in the database 88. If it is determined that the measurement mode of the blood sample 102 is the rapid mode, the process proceeds to step S304. On the other hand, if it is determined that the measurement mode of the blood sample 102 is not the rapid mode, the process proceeds to step S306.

[0099] In step S304 , the CPU 80A transmits an instruction to the analyzer 30 to perform measurement in the quick mode via the external communication unit 82 .

[0100] In step S306 , the CPU 80A transmits an instruction to the analyzing device 30 to perform measurement in the variant mode via the external communication unit 82 .

[0101] As described above, in the present embodiment, an instruction is sent from the management device 80 to the analysis device 30 to perform measurement in the selected measurement mode.

[0102] Next, the operation of this embodiment will be described.

[0103] In medical institutions, specimen tests such as hemoglobin analysis in blood are sometimes implemented in a clinical examination department that is equipped with various analytical devices and specializes in specimen analysis. In such medical institutions, sometimes the inspection content (measurement items) has been determined in each medical department (internal medicine, diabetes internal medicine, health examination department, etc.) that is the source of the inspection request. That is, in the analysis of hemoglobin in blood, sometimes it is determined whether to measure in a rapid mode or in a variant mode according to the medical department (the type of patient visiting the hospital). For example, in the diabetes internal medicine department, the measurement value of HbA1c is important in the diagnosis / treatment of diabetes. However, in the case where the patient has variant hemoglobin, the measurement result of HbA1c may be affected, so HbA1c is mostly separated from the variant hemoglobin and measured in a variant mode in which the measurement value of HbA1c is not easily affected. On the other hand, in the health examination department, the HbA1c measurement value is required as a screening test, so the measurement is performed in the rapid mode. When the detailed measurement in the variant mode is required based on the measurement results in the rapid mode, a specialist will perform a re-examination, so it is mostly used only in the rapid mode. In addition, specimens with different examination contents are mixed together when they arrive at the examination room where the specimens are examined. The operator in the examination room sets the measurement mode of the analyzer according to the examination content of the specimen. When the measurement mode is set according to the examination content of the specimen, it is necessary to be careful not to make setting errors, and there is a tendency for the burden on the operator to increase.

[0104] On the other hand, in the analysis system 20 of the present embodiment, even when specimens with different examination contents are mixed, that is, when blood collection tubes 100 measured in the rapid mode and the variant mode are mixed and stored in the rack 104, the management device 80 automatically selects the measurement mode of the analysis device 30 based on the information associating the measurement mode with the medical department information of the medical department that requested the examination set for the blood sample 102. Therefore, in the analysis system 20, for example, the burden on the examination operator is reduced compared with the case where the examination operator sets the measurement mode each time according to the examination contents requested by the medical department that requested the examination.

[0105] In the above embodiment, the management device 80 is connected to an analysis device 30 via a network line, but the present disclosure is not limited to this structure. Figure 5 As shown, multiple analysis devices 30 may be connected to the management device 80 via a network line. Figure 5 In the example of FIG. 8 , three analysis devices 30 are connected to a management device 80 via a network line.

[0106] In the above embodiment, the management device 80 and the analysis device 30 are connected via a network line, but the present disclosure is not limited to this structure. The control unit 70 of the analysis device 30 may also have the function of the management device 80. In this case, it is preferable to provide a database 88 in the analysis device 30.

[0107] In addition, in the above-mentioned embodiment, the information of the medical department is used as the information related to the inspection content of the blood sample 102, but the present disclosure is not limited to this structure. For example, the medical department information can also be associated with the information of the physician belonging to the medical department. In this case, the information of the medical department to which the physician belongs can be obtained from the information of the physician who has commissioned the blood test of the patient. In addition, the so-called physician's information is the physician's identification information, such as a barcode of the physician's inherent ID. As an example, in the case of an inspection request from a physician belonging to the health examination department, the measurement is performed in the rapid mode, and in the case of an inspection request from a physician belonging to the diabetes internal medicine department, the measurement is performed in the variant mode.

[0108] In the rapid mode of the above embodiment, liquid is fed to the analytical column 44 in the order of liquid A→liquid B→liquid A, and in the variant mode, liquid is fed to the analytical column 44 in the order of liquid A→liquid C→liquid A→liquid B→liquid A, but the present disclosure is not limited to this structure. For example, in the rapid mode, a solvent with a higher elution ability than in the variant mode can be used. Thus, the measurement time based on the rapid mode can be shortened.

[0109] In addition, for example, in the rapid mode, the solvent delivery speed can also be made faster than in the variant mode. Specifically, when the rapid mode is executed, the delivery speed can be increased by speeding up the rotation of the delivery pump 48 compared to when the variant mode is executed. Thus, the measurement time based on the rapid mode can be shortened.

[0110] In addition, for example, it can be that in the rapid mode, when the component as the object is detected, the eluent is switched to an eluent with high eluting power and the measurement is continued, and in the variant mode, even if the component as the object is detected, the eluent is not switched and the measurement is continued. Thus, the measurement time based on the rapid mode can be shortened.

[0111] In the above-mentioned present embodiment, the analysis device 30 using high performance liquid chromatography is managed by the management device 80, but the present disclosure is not limited to this structure. For example, a blood cell measuring device that measures the types of cells in the blood may also be managed by the management device 80. That is, the analysis system of the present disclosure may also be applied to a device that measures the types of cells in the blood. In addition, in the first measurement mode of the blood cell measuring device, only the normal cell types in the blood are measured as measurement items, and in the second measurement mode, abnormal cells different from the normal cell types in the blood are also measured as measurement items.

[0112] Furthermore, the present disclosure is not limited to the above, and can of course be implemented with various modifications other than the above without departing from the gist of the present disclosure.

[0113] The following notes are disclosed below.

[0114] (Note 1)

[0115] An analysis system comprising:

[0116] an analyzing unit that analyzes the sample and is capable of switching between a first measurement mode and a second measurement mode including measurement items different from those in the first measurement mode; and

[0117] The management unit selects a measurement mode from among the first measurement mode and the second measurement mode of the analysis unit based on information of the medical department that has requested the examination set for the sample.

[0118] (Note 2)

[0119] The analysis system according to note 1, wherein:

[0120] The information of the medical department is associated with the information of the physicians belonging to the medical department.

[0121] (Note 3)

[0122] The analytical system according to note 1 or note 2, wherein:

[0123] The analysis unit analyzes the sample by liquid chromatography.

[0124] (Note 4)

[0125] The analysis system according to note 3, wherein:

[0126] In the first measurement mode, hemoglobin A1c in the sample is measured.

[0127] In the second measurement mode, the variant hemoglobin in the sample is measured.

[0128] (Note 5)

[0129] The analytical system according to note 3 or note 4, wherein:

[0130] In the first measurement mode, a solvent having a higher elution ability than that in the second measurement mode is used.

[0131] (Note 6)

[0132] An analysis system according to any one of Notes 3 to 5, wherein:

[0133] In the first measurement mode, the solvent feeding speed is made faster than that in the second measurement mode.

[0134] (Note 7)

[0135] An analysis system according to any one of Notes 3 to 6, wherein:

[0136] In the first measurement mode, when the target component is detected, the solvent is switched to a solvent with a high eluting ability and the measurement is continued.

[0137] In the second measurement mode, even if the target component is detected, the measurement is continued without switching the solvent.

Claims

1. An analysis system comprising: an analyzing unit that analyzes the sample and is capable of switching between a first measurement mode and a second measurement mode including measurement items different from those in the first measurement mode; and The management unit selects a measurement mode from among the first measurement mode and the second measurement mode of the analysis unit based on information of the medical department that has requested the examination set for the sample.

2. The analysis system according to claim 1, wherein: The information of the medical department is associated with the information of the physicians belonging to the medical department.

3. The analysis system according to claim 1 or 2, wherein: The analysis unit analyzes the sample by liquid chromatography.

4. The analysis system according to claim 3, wherein: In the first measurement mode, hemoglobin A1c in the sample is measured, In the second measurement mode, the variant hemoglobin in the sample is measured.

5. The analysis system according to claim 3, wherein: In the first measurement mode, a solvent having a higher elution ability than that in the second measurement mode is used.

6. The analysis system according to claim 3, wherein: In the first measurement mode, the solvent feeding speed is made faster than that in the second measurement mode.

7. The analysis system according to claim 3, wherein: In the first measurement mode, when the target component is detected, the solvent is switched to a solvent with a high eluting ability and the measurement is continued. In the second measurement mode, even if the target component is detected, the measurement is continued without switching the solvent.